PVCT - PROVECTUS BIOPHARMACEUTICALS, INC.


0.0979
0.004   3.575%

Share volume: 20,835
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations: -0.13%

PREVIOUS CLOSE
CHG
CHG%

$0.09
0.00
0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 09-30-2024 12-31-2024
Fiscal Quarter Q3 2024 Q4 2024
Report Date 11-12-2024 03-27-2025
Total revenue 109.745 K 14.332 K
Cost of revenue 0.000 0.000
Gross profit 109.745 K 14.332 K
    -86.94%  
Operating expenses 1.065 M 2.349 M
Selling general and admin 651.486 K 1.792 M
Research and development 413.987 K 556.678 K
Total expenses 1.065 M 2.349 M
    120.45%  
Operating income -955.728 K -2.335 M
Ebit -955.728 K -2.335 M
Pretax income -1.014 M -2.397 M
    136.30%  
Income tax 0.000 0.000
Net income basic 0.000 0.000
       
Net income -1.014 M -2.397 M
    -136.30%